Morningstar
•
Aug 19, 2026
CRISPR Therapeutics AG: Crispr Earnings: Casgevy Gains Traction as Commercial Hurdles Begin to Ease
Summary
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Block, Inc.
Sep 04, 2026
•
XYZ
Market Digest: DG, HPE, PTON, SNOW
Sep 04, 2026
•
DG, SNOW, PTON, HPE
Analyst Report: Snowflake Inc
Sep 04, 2026
•
SNOW
Analyst Report: Illumina Inc
Sep 03, 2026
•
ILMN
Market Digest: ILMN, SLF, PANW, AXON
Sep 03, 2026
•
ILMN, AXON, SLF, PANW
